Crispr Therapeutics Ag
(CRSP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -366,252 | -153,610 | -650,175 | 377,661 | -348,865 |
| Depreciation Amortization | 19,259 | 19,837 | 24,172 | 17,953 | 11,041 |
| Accounts receivable | 175,000 | -200,000 | 305 | -161 | -45 |
| Other Working Capital | 156,270 | -193,585 | 19,845 | 26,859 | 33,440 |
| Other Operating Activity | -127,051 | 266,983 | 110,112 | 116,660 | 66,063 |
| Operating Cash Flow | $-142,774 | $-260,375 | $-495,741 | $538,972 | $-238,366 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -255,397 | 386,617 | -221,467 | -953,725 | -522,812 |
| PPE Investments | -1,901 | -9,470 | -37,188 | -81,705 | -18,358 |
| Purchase Of Investment | -23,183 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -2,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-280,481 | $374,647 | $-258,655 | $-1,035,430 | $-541,170 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 331,984 | 62,664 | 38,592 | 250,945 | 1,016,152 |
| Financing Cash Flow | $331,984 | $62,664 | $38,592 | $250,945 | $1,016,152 |
| Exchange Rate Effect | -21 | 73 | -80 | -11 | 40 |
| Beginning Cash Position | 401,068 | 224,060 | 939,944 | 1,185,468 | 948,812 |
| End Cash Position | 309,776 | 401,068 | 224,060 | 939,944 | 1,185,468 |
| Net Cash Flow | $-91,292 | $177,008 | $-715,884 | $-245,524 | $236,656 |
| Free Cash Flow | |||||
| Operating Cash Flow | -142,774 | -260,375 | -495,741 | 538,972 | -238,366 |
| Capital Expenditure | -1,901 | -9,470 | -37,188 | -81,705 | -18,358 |
| Free Cash Flow | -144,675 | -269,845 | -532,929 | 457,267 | -256,724 |